The effects of different therapeutic modalities on cardiovascular risk factors in women with polycyst ıc ovary syndrome: A randomızed controlled study
This study was designed to evaluate the effects of 3 mg drospirenone/30 μg ethinyl estradiol (OC) alone or combined with 1700 mg metformin on metabolic risk factors.
Source: Taiwanese Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Serkan Bodur, Ozgur Dundar, Mine Kanat-Pektas, Mehmet Ferdi Kinci, Levent Tutuncu Tags: Original Article Source Type: research
More News: Cardiology | Cardiovascular | Estradiol | Fortamet | Heart | Metformin | OBGYN | Ovaries | Study | Taiwan Health | Women | Yasmin | Yaz